Merck KGaA (Merck KGaA) Interest Expense : $-362 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Merck KGaA Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Merck KGaA's interest expense for the three months ended in Dec. 2023 was $ -41 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-362 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Merck KGaA's Operating Income for the three months ended in Dec. 2023 was $ 600 Mil. Merck KGaA's Interest Expense for the three months ended in Dec. 2023 was $ -41 Mil. Merck KGaA's Interest Coverage for the quarter that ended in Dec. 2023 was 14.47. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Merck KGaA Interest Expense Historical Data

The historical data trend for Merck KGaA's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Interest Expense Chart

Merck KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-528.89

-470.80

-307.35

-248.94

-350.06

Merck KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-16.95	-69.59	-161.43	-89.65	-41.44

Merck KGaA Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-362 Mil.

Merck KGaA (OTCPK:MKKGY) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Merck KGaA's Interest Expense for the three months ended in Dec. 2023 was $-41 Mil. Its Operating Income for the three months ended in Dec. 2023 was $600 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $10,075 Mil.

Merck KGaA's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	599.782	/	-41.439
	=	14.47

The higher the ratio, the stronger the company's financial strength is.

Merck KGaA (Merck KGaA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKKGY) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

MKGAF:USA MRK:Italy MRKd:UK 0O14:UK MRK:Germany MRCK:Austria

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.